Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: A prospective multicenter clinical trial

William J. Catalona*, Alan W. Partin, Kevin M. Slawin, Michael K. Brawer, Robert C. Flanigan, Anup Patel, Jerome P. Richie, Jean B. DeKernion, Patrick C. Walsh, Peter T. Scardino, Paul H. Lange, Eric N P Subong, Robert E. Parson, Gail H. Gasior, Kathleen G. Loveland, Paula C. Southwick

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

993 Scopus citations

Fingerprint

Dive into the research topics of 'Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: A prospective multicenter clinical trial'. Together they form a unique fingerprint.

Medicine and Dentistry

INIS